PL2306202T3 - Sposób wykrywania lub monitorowania złośliwej choroby nowotworowej komórek plazmatycznych - Google Patents

Sposób wykrywania lub monitorowania złośliwej choroby nowotworowej komórek plazmatycznych

Info

Publication number
PL2306202T3
PL2306202T3 PL10196249T PL10196249T PL2306202T3 PL 2306202 T3 PL2306202 T3 PL 2306202T3 PL 10196249 T PL10196249 T PL 10196249T PL 10196249 T PL10196249 T PL 10196249T PL 2306202 T3 PL2306202 T3 PL 2306202T3
Authority
PL
Poland
Prior art keywords
detecting
immunoglobulins
bound
monitoring
plasma cells
Prior art date
Application number
PL10196249T
Other languages
English (en)
Inventor
Arthur Bradwell
Original Assignee
The Binding Site Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Binding Site Group Ltd filed Critical The Binding Site Group Ltd
Publication of PL2306202T3 publication Critical patent/PL2306202T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL10196249T 2005-01-27 2006-01-26 Sposób wykrywania lub monitorowania złośliwej choroby nowotworowej komórek plazmatycznych PL2306202T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0501741.3A GB0501741D0 (en) 2005-01-27 2005-01-27 Antibody
EP10196249.6A EP2306202B1 (en) 2005-01-27 2006-01-26 Method of detecting or monitoring a malignant plasma cell disease
EP06703629.3A EP1842071B3 (en) 2005-01-27 2006-01-26 Method of detecting or monitoring a malignant plasma cell disease

Publications (1)

Publication Number Publication Date
PL2306202T3 true PL2306202T3 (pl) 2014-05-30

Family

ID=34259791

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10196249T PL2306202T3 (pl) 2005-01-27 2006-01-26 Sposób wykrywania lub monitorowania złośliwej choroby nowotworowej komórek plazmatycznych

Country Status (11)

Country Link
US (3) US7897353B2 (pl)
EP (2) EP2306202B1 (pl)
JP (3) JP5431674B2 (pl)
AT (1) ATE502302T1 (pl)
DE (1) DE602006020688D1 (pl)
DK (1) DK2306202T3 (pl)
ES (2) ES2455440T3 (pl)
GB (1) GB0501741D0 (pl)
PL (1) PL2306202T3 (pl)
PT (1) PT2306202E (pl)
WO (1) WO2006079816A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0608444D0 (en) 2006-04-27 2006-06-07 Binding Site The Ltd Dialysis
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain
TW201038286A (en) 2009-04-01 2010-11-01 Genentech Inc Anti-FcRH5 antibodies and immunoconjugates and methods of use
GB0914535D0 (en) * 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
GB201001946D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB201001950D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
GB201012049D0 (en) 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
GB201203938D0 (en) * 2012-03-06 2012-04-18 Binding Site Group The Ltd Assay system
WO2014150170A1 (en) * 2013-03-15 2014-09-25 Mayo Foundation For Medical Education And Research Identification and monitoring of monoclonal immunoglobulins by molecular mass
US9550004B2 (en) 2013-09-06 2017-01-24 Sensor Electronic Technology, Inc. Ultraviolet diffusive illumination
US10267806B2 (en) 2014-04-04 2019-04-23 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
GB201511364D0 (en) * 2015-06-29 2015-08-12 Binding Site Group The Ltd Method of detecting or monitoring an IgG4-related disease
GB2541027A (en) * 2015-08-07 2017-02-08 The Binding Site Group Ltd Treatment
GB201603291D0 (en) * 2016-02-25 2016-04-13 Binding Site Group The Ltd Antibodies
EP3681528B1 (en) 2017-09-13 2025-07-23 Mayo Foundation for Medical Education and Research Identification and monitoring of apoptosis inhibitor of macrophage
WO2019055632A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN CHAINS J
WO2021202992A2 (en) * 2020-04-03 2021-10-07 Lawrence Loomis Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19
GB202007047D0 (en) * 2020-05-13 2020-06-24 Binding Site Group Ltd Mass spectrometry controls

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907502A (en) * 1973-12-11 1975-09-23 Miless L Brink Method for identifying Bence Jones proteins
WO1982000364A1 (en) 1980-07-16 1982-02-04 Jefferis R Methods of immuno-analysis using monoclonal antibodies
JPS63139199A (ja) * 1986-12-01 1988-06-10 Wakunaga Pharmaceut Co Ltd 抗ヒトＩｇＥモノクロ−ナル抗体及びその用途
GB2204398B (en) 1987-04-27 1991-08-28 Unilever Plc Analytical test device for use in assays
US4983530A (en) * 1988-01-29 1991-01-08 E. I. Du Pont De Nemours And Company Sandwich immunoassay for determination of total monoclonal IGG
US5185066A (en) * 1988-08-11 1993-02-09 Helena Laboratories Corporation Immunofixation electrophoresis control system
JPH03199966A (ja) * 1989-12-27 1991-08-30 Kazutomo Wakasugi 遊離型ｌ鎖の測定方法
JPH04262792A (ja) * 1990-01-12 1992-09-18 Takeda Chem Ind Ltd 蛋白質の精製法
US5228960A (en) * 1992-07-17 1993-07-20 Beckman Instruments, Inc. Analysis of samples by capillary electrophoretic immunosubtraction
US5552277A (en) * 1994-07-19 1996-09-03 The Johns Hopkins University School Of Medicine Genetic diagnosis of prostate cancer
ES2233980T3 (es) * 1995-11-03 2005-06-16 The Binding Site Limited Produccion de anticuerpos.
GB9718911D0 (en) * 1997-09-05 1997-11-12 Orion Yhtymae Oy Monoclonal antibodies
US7491796B1 (en) * 1998-11-19 2009-02-17 Merrion Research Iii Limited Retro-inversion peptides that target GIT receptors and related methods
CA2436516A1 (en) * 2001-02-20 2002-08-29 Caroline Barry Pg-3 and biallelic markers thereof
US20020182748A1 (en) * 2001-03-30 2002-12-05 Reardon Paul C. Method and device for testing for Bence-Jones Protein
EP1449851A4 (en) * 2001-11-27 2005-11-16 Mochida Pharm Co Ltd NEUTRALIZING ANTIBODIES OF IL13 ALPHA RECEPTOR 1
US20040018576A1 (en) 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
CA2515699C (en) * 2003-02-10 2015-01-27 Aya Jakobovits Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
EP2289559B1 (en) * 2003-02-20 2014-02-12 Seattle Genetics, Inc. Anit-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
JP4473257B2 (ja) * 2003-04-02 2010-06-02 エフ．ホフマン−ラ ロシュ アーゲー インスリン様成長因子ｉ受容体に対する抗体及びその使用
JP4286256B2 (ja) * 2003-11-19 2009-06-24 ヤマサ醤油株式会社 ベンスジョーンズ蛋白質の検定法
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein

Also Published As

Publication number Publication date
JP2008528995A (ja) 2008-07-31
DK2306202T3 (da) 2014-02-10
EP1842071B3 (en) 2014-02-26
US8592561B2 (en) 2013-11-26
JP5431674B2 (ja) 2014-03-05
US7897353B2 (en) 2011-03-01
JP2014025950A (ja) 2014-02-06
US20110177977A1 (en) 2011-07-21
JP6007134B2 (ja) 2016-10-12
US20110177535A1 (en) 2011-07-21
ES2455440T3 (es) 2014-04-15
ATE502302T1 (de) 2011-04-15
EP1842071B1 (en) 2011-03-16
ES2365626T7 (es) 2014-06-04
ES2365626T3 (es) 2011-10-07
EP1842071A1 (en) 2007-10-10
EP2306202B1 (en) 2013-12-18
WO2006079816A1 (en) 2006-08-03
JP2013147499A (ja) 2013-08-01
US8415110B2 (en) 2013-04-09
US20080166742A1 (en) 2008-07-10
PT2306202E (pt) 2014-02-27
EP2306202A1 (en) 2011-04-06
JP5715671B2 (ja) 2015-05-13
GB0501741D0 (en) 2005-03-02
DE602006020688D1 (de) 2011-04-28

Similar Documents

Publication Publication Date Title
PL2306202T3 (pl) Sposób wykrywania lub monitorowania złośliwej choroby nowotworowej komórek plazmatycznych
ATE410684T1 (de) Molekular-modifikations-assays
CA2548164A1 (en) Assay kit for detecting analytes of interest in samples
WO2009058902A3 (en) Methods and devices for analyte detection
WO2009117510A3 (en) Multi-wavelength analyses of sol-particle specific binding assays
WO2007035633A3 (en) Screening assays and methods
WO2008007242A3 (en) Increased specificity of analyte detection by measurement of bound and unbound labels
WO2010049672A3 (en) Methods and products for measuring free immunoglobulin light chain molecules
WO2010096674A3 (en) A+ biomarker assays
ATE532830T1 (de) Langwellige thiolgruppenreaktive fluorophore
BRPI0316384B8 (pt) imunoensaio não competitivo para analitos pequenos
ATE274699T1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
Chocarro-Ruiz et al. Interferometric nanoimmunosensor for label-free and real-time monitoring of Irgarol 1051 in seawater
ATE520029T1 (de) Biochemisches gerät und nachweisverfahren
WO2001073443A3 (en) Methods and compositions for the simultaneous detection of multiple analytes
JP2008528995A5 (pl)
FR2853077B1 (fr) Procedes immunochromatographiques en phase solide
WO2008081331A3 (en) Enhancing the level of antibody expression by framework re-engineering
WO2007001895A3 (en) Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
ATE511650T1 (de) Verfahren zum nachweis von antikörpern einer bestimmten klasse über einen immunkomplex spezifischen antikörper
WO2002079783A3 (en) Method and device for testing for bence-jones protein
AU2003248619A1 (en) Method for the elimination of interferences in immunochromatographic assays
ATE529749T1 (de) Chromatographische teststreifen für ein oder mehrere analyte
JP2018519525A5 (pl)
DE60332479D1 (de) Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest